| 货号 |
中文名 |
英文名 |
品牌 |
规格 |
价格 |
详细 |
| C323-200 μg |
Anti-Human ICAM-1 - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human ICAM-1 - APC |
Leinco |
200μg |
5465 |
More |
| C3233-100mg |
Anti-Mouse CD27 (Clone RM27-3E5) - Recombinant in vivo Functional Grade - 100 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Mouse CD27 (Clone RM27-3E5) - Recombinant in vivo Functional Grade - 100 mg |
Leinco |
100 mg |
36050 |
More |
| C3233-1mg |
Anti-Mouse CD27 (Clone RM27-3E5) - Recombinant in vivo Functional Grade - 1 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Mouse CD27 (Clone RM27-3E5) - Recombinant in vivo Functional Grade - 1 mg |
Leinco |
1 mg |
1470 |
More |
| C3233-25mg |
Anti-Mouse CD27 (Clone RM27-3E5) - Recombinant in vivo Functional Grade - 25 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Mouse CD27 (Clone RM27-3E5) - Recombinant in vivo Functional Grade - 25 mg |
Leinco |
25 mg |
16100 |
More |
| C3233-50mg |
Anti-Mouse CD27 (Clone RM27-3E5) - Recombinant in vivo Functional Grade - 50 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Mouse CD27 (Clone RM27-3E5) - Recombinant in vivo Functional Grade - 50 mg |
Leinco |
50 mg |
25550 |
More |
| C3233-5mg |
Anti-Mouse CD27 (Clone RM27-3E5) - Recombinant in vivo Functional Grade - 5 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Mouse CD27 (Clone RM27-3E5) - Recombinant in vivo Functional Grade - 5 mg |
Leinco |
5 mg |
5040 |
More |
| C323-50 μg |
Anti-Human ICAM-1 - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human ICAM-1 - APC |
Leinco |
50μg |
1739 |
More |
| C3240-1.0mg |
Anti-Human CD137 (4-1BB) (Urelumab) - 1 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD137 (4-1BB) (Urelumab) - 1 mg |
Leinco |
1 mg |
2001 |
More |
| C3240-100mg |
Anti-Human CD137 (4-1BB) (Urelumab) - 100 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD137 (4-1BB) (Urelumab) - 100 mg |
Leinco |
100 mg |
68310 |
More |
| C3240-25mg |
Anti-Human CD137 (4-1BB) (Urelumab) - 25 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD137 (4-1BB) (Urelumab) - 25 mg |
Leinco |
25 mg |
27255 |
More |
| C3240-50mg |
Anti-Human CD137 (4-1BB) (Urelumab) - 50 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD137 (4-1BB) (Urelumab) - 50 mg |
Leinco |
50 mg |
48300 |
More |
| C3240-5mg |
Anti-Human CD137 (4-1BB) (Urelumab) - 5 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD137 (4-1BB) (Urelumab) - 5 mg |
Leinco |
5 mg |
7590 |
More |
| C3245-500μg |
Anti-Human CD137 (4-1BB) (Urelumab) – Fc Muted? - 500 μg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD137 (4-1BB) (Urelumab) – Fc Muted? - 500 μg |
Leinco |
500 μg |
5451 |
More |
| C3250-1.0mg |
Anti-human CD134 (OX40) (Vonlerolizumab) - 1 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-human CD134 (OX40) (Vonlerolizumab) - 1 mg |
Leinco |
1 mg |
2001 |
More |
| C3250-100mg |
Anti-human CD134 (OX40) (Vonlerolizumab) - 100 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-human CD134 (OX40) (Vonlerolizumab) - 100 mg |
Leinco |
100 mg |
68310 |
More |
| C3250-25mg |
Anti-human CD134 (OX40) (Vonlerolizumab) - 25 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-human CD134 (OX40) (Vonlerolizumab) - 25 mg |
Leinco |
25 mg |
27255 |
More |
| C3250-50mg |
Anti-human CD134 (OX40) (Vonlerolizumab) - 50 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-human CD134 (OX40) (Vonlerolizumab) - 50 mg |
Leinco |
50 mg |
48300 |
More |
| C3250-5mg |
Anti-human CD134 (OX40) (Vonlerolizumab) - 5 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-human CD134 (OX40) (Vonlerolizumab) - 5 mg |
Leinco |
5 mg |
7590 |
More |
| C325-100 μg |
Anti-Human CD57 (Clone VC1.1) - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD57 (Clone VC1.1) - APC |
Leinco |
100μg |
3105 |
More |
| C325-200 μg |
Anti-Human CD57 (Clone VC1.1) - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD57 (Clone VC1.1) - APC |
Leinco |
200μg |
5465 |
More |
| C325-50 μg |
Anti-Human CD57 (Clone VC1.1) - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD57 (Clone VC1.1) - APC |
Leinco |
50μg |
1739 |
More |
| C3255-500μg |
Anti-human CD134 (OX40) (Vonlerolizumab) – Fc Muted? - 500 μg Leinco-北京博迈斯科技发展有限公司 |
Anti-human CD134 (OX40) (Vonlerolizumab) – Fc Muted? - 500 μg |
Leinco |
500 μg |
5451 |
More |
| C3260-1.0mg |
Anti-Human CD3 x CD20 (Epcoritamab) - 1 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x CD20 (Epcoritamab) - 1 mg |
Leinco |
1 mg |
2001 |
More |
| C3260-100mg |
Anti-Human CD3 x CD20 (Epcoritamab) - 100 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x CD20 (Epcoritamab) - 100 mg |
Leinco |
100 mg |
68310 |
More |
| C3260-25mg |
Anti-Human CD3 x CD20 (Epcoritamab) - 25 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x CD20 (Epcoritamab) - 25 mg |
Leinco |
25 mg |
27255 |
More |
| C3260-50mg |
Anti-Human CD3 x CD20 (Epcoritamab) - 50 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x CD20 (Epcoritamab) - 50 mg |
Leinco |
50 mg |
48300 |
More |
| C3260-5mg |
Anti-Human CD3 x CD20 (Epcoritamab) - 5 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x CD20 (Epcoritamab) - 5 mg |
Leinco |
5 mg |
7590 |
More |
| C326-100 μg |
Anti-Human CDw60 - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CDw60 - APC |
Leinco |
100μg |
3105 |
More |
| C326-200 μg |
Anti-Human CDw60 - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CDw60 - APC |
Leinco |
200μg |
5465 |
More |
| C326-50 μg |
Anti-Human CDw60 - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CDw60 - APC |
Leinco |
50μg |
1739 |
More |
| C3270-1.0mg |
Anti-Human CD3 x BCMA (Elranatamab) - 1 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x BCMA (Elranatamab) - 1 mg |
Leinco |
1 mg |
2001 |
More |
| C3270-100mg |
Anti-Human CD3 x BCMA (Elranatamab) - 100 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x BCMA (Elranatamab) - 100 mg |
Leinco |
100 mg |
68310 |
More |
| C3265-500μg |
Anti-Human CD3 x CD20 (Epcoritamab) – Fc Muted? - 500 μg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x CD20 (Epcoritamab) – Fc Muted? - 500 μg |
Leinco |
500 μg |
5451 |
More |
| C3270-25mg |
Anti-Human CD3 x BCMA (Elranatamab) - 25 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x BCMA (Elranatamab) - 25 mg |
Leinco |
25 mg |
27255 |
More |
| C3270-50mg |
Anti-Human CD3 x BCMA (Elranatamab) - 50 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x BCMA (Elranatamab) - 50 mg |
Leinco |
50 mg |
48300 |
More |
| C3270-5mg |
Anti-Human CD3 x BCMA (Elranatamab) - 5 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x BCMA (Elranatamab) - 5 mg |
Leinco |
5 mg |
7590 |
More |
| C327-100 μg |
Anti-Human CD61 (Integrin β3) - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD61 (Integrin β3) - APC |
Leinco |
100μg |
3105 |
More |
| C327-200 μg |
Anti-Human CD61 (Integrin β3) - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD61 (Integrin β3) - APC |
Leinco |
200μg |
5465 |
More |
| C327-50 μg |
Anti-Human CD61 (Integrin β3) - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD61 (Integrin β3) - APC |
Leinco |
50μg |
1739 |
More |
| C3275-500μg |
Anti-Human CD3 x BCMA (Elranatamab) – Fc Muted? - 500 μg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x BCMA (Elranatamab) – Fc Muted? - 500 μg |
Leinco |
500 μg |
5451 |
More |
| C3280-1.0mg |
Anti-Human CD3 x GPRC5D (Talquetamab) - 1 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x GPRC5D (Talquetamab) - 1 mg |
Leinco |
1 mg |
2001 |
More |
| C3280-100mg |
Anti-Human CD3 x GPRC5D (Talquetamab) - 100 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x GPRC5D (Talquetamab) - 100 mg |
Leinco |
100 mg |
68310 |
More |
| C3280-25mg |
Anti-Human CD3 x GPRC5D (Talquetamab) - 25 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x GPRC5D (Talquetamab) - 25 mg |
Leinco |
25 mg |
27255 |
More |
| C3280-50mg |
Anti-Human CD3 x GPRC5D (Talquetamab) - 50 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x GPRC5D (Talquetamab) - 50 mg |
Leinco |
50 mg |
48300 |
More |
| C3280-5mg |
Anti-Human CD3 x GPRC5D (Talquetamab) - 5 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x GPRC5D (Talquetamab) - 5 mg |
Leinco |
5 mg |
7590 |
More |
| C328-100 μg |
Anti-Human CD71 - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD71 - APC |
Leinco |
100μg |
3105 |
More |
| C328-200 μg |
Anti-Human CD71 - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD71 - APC |
Leinco |
200μg |
5465 |
More |
| C328-50 μg |
Anti-Human CD71 - APC Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD71 - APC |
Leinco |
50μg |
1739 |
More |
| C3285-500μg |
Anti-Human CD3 x GPRC5D (Talquetamab) – Fc Muted? - 500 μg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human CD3 x GPRC5D (Talquetamab) – Fc Muted? - 500 μg |
Leinco |
500 μg |
5451 |
More |
| C3290-100mg |
Anti-Human C5 (Ravulizumab) - 100 mg Leinco-北京博迈斯科技发展有限公司 |
Anti-Human C5 (Ravulizumab) - 100 mg |
Leinco |
100 mg |
68310 |
More |
